mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
-0.0087 |
1 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |